New Method to Track Huntington's Disease Progression

Scientists have developed a new non-invasive method to track the progression of Huntington's disease.

Huntington's disease is a fatal, inherited neurodegenerative disorder caused by a mutation in the gene encoding huntingtin. Expresion of mutant huntingtin (mHTT) protein is correlated with the onset and progression of the disease and new therapies are being developed to reduce the expression of mHTT. In order to evaluate these new therapies, researchers need to be able to quantify the amount of mHTT in a particular patient; however, non-invasive quantification of mHTT isn't currently possible. In this issue of the Journal of Clinical Investigation, researchers led by Sarah Tabrizi at University College London report that mHTT can be detected in immune cells isolated during a normal blood draw. mHTT levels were significantly correlated with disease symptom severity, indicating that this test could serve as a non-invasive biomarker for Huntington's disease.

About DNA Fingerprinting
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, identity thefts, legal suits and terrorism cases.

Source-Eurekalert

Know Your Body - Nervous system
Know about Nervous system, which consists of network of specialized cells that transmits the signal between different parts of the body.

How to Best Treat Involuntary Movements in Huntington's Disease
A new guideline recommends several treatments for people with Huntington's disease who experience chorea—jerky, random, uncontrollable movements that can make everyday activities challenging.

Way to Treat Huntington's Disease may be Developed Via Two New Proteins
Two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington''s disease (HD) have been identified